NDTDI

NDTDI, also known as 9-desmethine-LSD, 9-nor-LSD, or 8,10-seco-LSD, is a psychedelic drug related to lysergic acid diethylamide (LSD). It is a tricyclic cyclized tryptamine and partial lysergamide and is a structurally simplified analogue of LSD. The drug is specifically the analogue of LSD in which the carbon atom at position 9 of the ergoline ring system has been removed. It has been reported to produce psychedelic effects similarly to LSD, but with much lower potency. The pharmacology of NDTDI has not been studied. NDTDI was encountered as a novel designer drug by 2016.

Also known as: N,N-diethyl-3-[methyl(1,3,4,5-tetrahydrobenzo[ cd]indol-4-yl)amino] propanamide, 9-nor-LSD

Classification

Chemical: Tryptamine
Psychoactive: Psychedelic
Tag: substituted tryptamine

Effects

Dilated Pupils
Nausea
Stimulation
Pupil Dilation
Restlessness
Spontaneous Bodily Sensations
Introspection
Confusion
Novelty Enhancement
Memory Suppression
Time Distortion
Euphoria
Visual Distortion
Color Enhancement
Drifting
Tracers
Color Shifting
Auditory Distortion

Routes of Administration

No route information available yet.

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

wikipedia.org

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu